Luciano Merlini

The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice.

Tania Tiepolo, Alessia Angelin, +10 authors Pernelle Bernardi
British journal of pharmacology
2009

BACKGROUND AND PURPOSE We have investigated the therapeutic effects of the selective cyclophilin inhibitor D-MeAla(3)-EtVal(4)-cyclosporin (Debio 025) in myopathic Col6a1(-/-) mice, a model of… (More)

Hereditary motor and sensory neuropathy Lom

L Kalaydijeva, Roy King, +11 authors Pontzen Thomas
2001

Measuring muscle strength in clinical trials

Luciano Merlini
The Lancet Neurology
2010

Autophagy activation in COL6 myopathic patients by a low-protein-diet pilot trial

Silvia Castagnaro, Camilla Pellegrini, +13 authors Luciano Merlini
Autophagy
2016

A pilot clinical trial based on nutritional modulation was designed to assess the efficacy of a one-year low-protein diet in activating autophagy in skeletal muscle of patients affected by… (More)

The Pompe Registry: Centralized Data Collection to Track the Natural Course of Pompe Disease

CIR-Myo News: Abstracts of the 2015 Spring Padua Muscle Days

Stanley Salmons, Kyle Joseph Edmunds, +239 authors Carraro U
2015

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 3.0) which permits any noncommercial use, distribution, and reproduction in any medium,… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences